Morgan Stanley Sol Gel Technologies Ltd. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Morgan Stanley holds 92,360 shares of SLGL stock, worth $678,846. This represents 0.0% of its overall portfolio holdings.

Number of Shares

92,360

Previous 88,239 4.67%

Holding current value

$678,846

Previous $82,000 41.46%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$0.52 - $1.3 $2,142 - $5,357	4,121 Added 4.67%	92,360 $48,000
Q4 2024 Feb 14, 2025	BUY	$0.43 - $1.65 $23,597 - $90,550	54,879 Added 164.51%	88,239 $82,000
Q3 2024 May 14, 2025	SELL	$0.37 - $0.96 $12,006 - $31,151	-32,449 Reduced 49.31%	33,360 $22,000
Q3 2024 Nov 14, 2024	SELL	$0.37 - $0.96 $12,006 - $31,151	-32,449 Reduced 49.31%	33,360 $22,000
Q2 2024 May 14, 2025	SELL	$0.66 - $1.05 $14,803 - $23,551	-22,430 Reduced 25.42%	65,809 $58,000
Q2 2024 Oct 17, 2024	BUY	$0.66 - $1.05 $17,968 - $28,586	27,225 Added 70.56%	65,809 $58,000
Q2 2024 Aug 14, 2024	BUY	$0.66 - $1.05 $17,968 - $28,586	27,225 Added 70.56%	65,809 $58,000
Q1 2024 Oct 17, 2024	SELL	$0.95 - $1.5 $25,863 - $40,837	-27,225 Reduced 41.37%	38,584 $37,000
Q1 2024 Aug 16, 2024	BUY	$0.95 - $1.5 $9,166 - $14,473	9,649 Added 33.35%	38,584 $37,000
Q1 2024 May 15, 2024	BUY	$0.95 - $1.5 $9,166 - $14,473	9,649 Added 33.35%	38,584 $37,000
Q4 2023 Aug 16, 2024	SELL	$0.92 - $1.6 $33,924 - $58,998	-36,874 Reduced 56.03%	28,935 $31,000
Q4 2023 Feb 13, 2024	SELL	$0.92 - $1.6 $276 - $480	-300 Reduced 1.03%	28,935 $31,000
Q3 2023 Nov 15, 2023	SELL	$1.63 - $3.94 $5,959 - $14,404	-3,656 Reduced 11.12%	29,235 $47,000
Q2 2023 Aug 14, 2023	BUY	$2.99 - $4.15 $8,838 - $12,267	2,956 Added 9.87%	32,891 $98,000
Q1 2023 May 15, 2023	BUY	$3.44 - $5.32 $1,032 - $1,596	300 Added 1.01%	29,935 $116,000
Q4 2022 Feb 14, 2023	SELL	$4.26 - $5.22 $16,196 - $19,846	-3,802 Reduced 11.37%	29,635 $135,000
Q3 2022 Nov 14, 2022	SELL	$4.16 - $6.4 $14,551 - $22,387	-3,498 Reduced 9.47%	33,437 $167,000
Q2 2022 Oct 27, 2022	BUY	$4.1 - $7.36 $13,529 - $24,288	3,300 Added 9.81%	36,935 $151,000
Q2 2022 Aug 15, 2022	BUY	$4.1 - $7.36 $13,529 - $24,288	3,300 Added 9.81%	36,935 $151,000
Q1 2022 Oct 27, 2022	SELL	$6.64 - $8.21 $21,912 - $27,093	-3,300 Reduced 8.93%	33,635 $248,000
Q1 2022 May 13, 2022	SELL	$6.64 - $8.21 $5,976 - $7,389	-900 Reduced 2.61%	33,635 $248,000
Q4 2021 Feb 14, 2022	SELL	$6.57 - $9.78 $8,541 - $12,714	-1,300 Reduced 3.63%	34,535 $255,000
Q3 2021 Nov 15, 2021	BUY	$8.85 - $12.5 $317,139 - $447,937	35,835 New	35,835 $359,000

Others Institutions Holding SLGL

# of Institutions

Shares Held

5.38M

Call Options Held

20.1K

Put Options Held

View Full List

About Sol-Gel Technologies Ltd.

Ticker SLGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,129,500
Market Cap $170M
Description
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...

More about SLGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account